Evidence map›Paper›PMID 29676690›Full record

ArticleJournal of neurosurgery2019

Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.

Jaymin Jhaveri, Mudit Chowdhary, Xinyan Zhang, Robert H Press, Jeffrey M Switchenko, Matthew J Ferris, Tiffany M Morgan, Justin Roper, Anees Dhabaan, Eric Elder and 6 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of neurosurgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05554302 phase2recruitingnot on this mapstarted 2023, after this paper: background citation

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

TypeinterventionalSponsorBaptist Health South FloridaRan2023 to 2030Enrolled20ConditionsBrain Metastases, Brain CancerArms18F-Fluciclovine
NCT05868928 unknown statusnot on this mapstarted 2023, after this paper: background citation

Imaging Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis (IRRAS-BM)

Typeobservational_patient_registrySponsorAsan Medical CenterRan2023 to 2026Enrolled132ConditionsBrain Metastases, RadiosurgeryArmsMagnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling (ASL), Dynamic susceptibility contrast-MRI (DSC-MRI)
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Surface guided radiation therapy with an innovative open-face mask and mouth bite: patient motion management in brain stereotactic radiotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jaymin JhaveriDepartments of1Radiation Oncology and.
Mudit ChowdharyDepartments of1Radiation Oncology and.
Xinyan Zhang4Biostatistics and Bioinformatics Shared Resource.
Robert H PressDepartments of1Radiation Oncology and.
Jeffrey M Switchenko4Biostatistics and Bioinformatics Shared Resource.
Matthew J FerrisDepartments of1Radiation Oncology and.
Tiffany M MorganDepartments of1Radiation Oncology and.
Justin RoperDepartments of1Radiation Oncology and.
Anees DhabaanDepartments of1Radiation Oncology and.
Eric ElderDepartments of1Radiation Oncology and.
Bree R EatonDepartments of1Radiation Oncology and.
Jeffrey J Olson2Winship Cancer Institute, Emory University, Atlanta, Georgia.
Walter J CurranDepartments of1Radiation Oncology and.
Hui-Kuo G ShuDepartments of1Radiation Oncology and.
Ian R CrockerDepartments of1Radiation Oncology and.
Kirtesh R PatelDepartments of1Radiation Oncology and.

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
NCI NIH HHS P30 CA138292
6 · The paper itself

Abstract

objectiveThe optimal margin size in postoperative stereotactic radiosurgery (SRS) for brain metastases is unknown. Herein, the authors investigated the effect of SRS planning target volume (PTV) margin on local recurrence and symptomatic radiation necrosis postoperatively.

methodsRecords of patients who received postoperative LINAC-based SRS for brain metastases between 2006 and 2016 were reviewed and stratified based on PTV margin size (1.0 or > 1.0 mm). Patients were treated using frameless and framed SRS techniques, and both single-fraction and hypofractionated dosing were used based on lesion size. Kaplan-Meier and cumulative incidence models were used to estimate survival and intracranial outcomes, respectively. Multivariate analyses were also performed.

resultsA total of 133 patients with 139 cavities were identified; 36 patients (27.1%) and 35 lesions (25.2%) were in the 1.0-mm group, and 97 patients (72.9%) and 104 lesions (74.8%) were in the > 1.0-mm group. Patient characteristics were balanced, except the 1.0-mm cohort had a better Eastern Cooperative Group Performance Status (grade 0: 36.1% vs 19.6%), higher mean number of brain metastases (1.75 vs 1.31), lower prescription isodose line (80% vs 95%), and lower median single fraction-equivalent dose (15.0 vs 17.5 Gy) (all p < 0.05). The median survival and follow-up for all patients were 15.6 months and 17.7 months, respectively. No significant difference in local recurrence was noted between the cohorts. An increased 1-year rate of symptomatic radionecrosis was seen in the larger margin group (20.9% vs 6.0%, p = 0.028). On multivariate analyses, margin size > 1.0 mm was associated with an increased risk for symptomatic radionecrosis (HR 3.07, 95% CI 1.13-8.34; p = 0.028), while multifraction SRS emerged as a protective factor for symptomatic radionecrosis (HR 0.13, 95% CI 0.02-0.76; p = 0.023).

conclusionsExpanding the PTV margin beyond 1.0 mm is not associated with improved local recurrence but appears to increase the risk of symptomatic radionecrosis after postoperative SRS.

Indexed as

Margins of ExcisionPatient Care PlanningAdultAgedAged, 80 and overBrain NeoplasmsCohort StudiesCraniotomyFemaleFollow-Up StudiesHumansKaplan-Meier EstimateMaleMiddle AgedNecrosisNeoplasm Recurrence, LocalECOG = Eastern Cooperative GroupGTR = gross-total resectionGTV = gross tumor volumeIDL = isodose lineLINAC = linear acceleratormarginMVA = multivariate analysisoncologyOS = overall survivalplanning target volumePTV = planning target volumeresected brain metastasesSFED = single fraction–equivalent doseSRS = stereotactic radiosurgerystereotactic radiosurgerySTR = subtotal resectionsymptomatic radiation necrosisWBRT = whole-brain radiation therapy

Identifiers

PMID29676690
PMCPMC6195865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.